St. Jude Medical VP Unloads $544,875 in Stock (STJ)
St. Jude Medical (NYSE:STJ) VP Kathy Chester unloaded 9,375 shares of St. Jude Medical stock on the open market in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $58.12, for a total transaction of $544,875.00. Following the transaction, the vice president now directly owns 4,830 shares in the company, valued at approximately $280,720. The transaction was disclosed in a filing with the SEC, which is available at this link.
STJ has been the subject of a number of recent research reports. Analysts at RBC Capital raised their price target on shares of St. Jude Medical from $40.00 to $44.00 in a research note to investors on Thursday, October 17th. They now have an “underperform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of St. Jude Medical in a research note to investors on Thursday, October 17th. They now have a $59.00 price target on the stock. Finally, analysts at Credit Suisse raised their price target on shares of St. Jude Medical from $55.00 to $60.00 in a research note to investors on Thursday, October 17th. They now have an “outperform” rating on the stock. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and twelve have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $49.80.
Shares of St. Jude Medical (NYSE:STJ) traded down 0.74% on Thursday, hitting $57.39. The stock had a trading volume of 1,885,706 shares. St. Jude Medical has a one year low of $30.25 and a one year high of $58.51. The stock’s 50-day moving average is $55.00 and its 200-day moving average is $49.19. The company has a market cap of $16.758 billion and a price-to-earnings ratio of 23.61.
St. Jude Medical (NYSE:STJ) last posted its earnings results on Wednesday, October 16th. The company reported $0.90 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.89 by $0.01. The company had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter last year, the company posted $0.83 earnings per share. St. Jude Medical’s revenue was up .9% compared to the same quarter last year. Analysts expect that St. Jude Medical will post $3.73 EPS for the current fiscal year.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.